-
公开(公告)号:US20240279159A1
公开(公告)日:2024-08-22
申请号:US18571801
申请日:2022-06-14
申请人: BASF SE
发明人: Marc Heinrich , Gunther Zimmermann , Markus Kordes , Tobias Seiser , Trevor William Newton , Gerd Kraemer
IPC分类号: C07C233/63 , A01N37/30 , A01N43/08 , A01P13/00 , C07D307/30 , C07D407/12
CPC分类号: C07C233/63 , A01N37/30 , A01N43/08 , A01P13/00 , C07D307/30 , C07D407/12
摘要: The invention relates to compounds of formula (I), and their use as herbicides. In said formula, R1 to R8 represent groups such as hydrogen, halo-gen or organic groups such as alkyl, alkenyl, alkynyl, or alkoxy; W1 and W2 are —CR9R10—, —C(O)—, —O—, X is a bond or a divalent unit; Y is hydrogen, cyano, hydroxyl or a linear or cyclic organic group. The invention further refers to a composition comprising such compound and to the use thereof for controlling unwanted vegetation.
-
公开(公告)号:US20240199535A1
公开(公告)日:2024-06-20
申请号:US18554365
申请日:2022-04-08
申请人: IMMUNIC AG
发明人: Christian GEGE , Hella KOHLHOF , Andreas MÜHLER , Daniel VITT
IPC分类号: C07C233/75 , A61K31/16 , A61K31/167 , A61K31/341 , A61K31/381 , A61K31/426 , A61K31/437 , A61K31/44 , A61K31/472 , A61K31/5375 , A61P31/14 , C07C233/74 , C07D213/68 , C07D213/73 , C07D217/04 , C07D265/30 , C07D277/34 , C07D307/30 , C07D333/40 , C07D471/04
CPC分类号: C07C233/75 , A61K31/16 , A61K31/167 , A61K31/341 , A61K31/381 , A61K31/426 , A61K31/437 , A61K31/44 , A61K31/472 , A61K31/5375 , A61P31/14 , C07C233/74 , C07D213/68 , C07D213/73 , C07D217/04 , C07D265/30 , C07D277/34 , C07D307/30 , C07D333/40 , C07D471/04
摘要: The invention relates to novel deuterated compounds of Formula (I)
and their use as medicaments.-
公开(公告)号:US20240116847A1
公开(公告)日:2024-04-11
申请号:US18370574
申请日:2023-09-20
申请人: CORSAIR PHARMA, INC.
IPC分类号: C07C69/734 , A61K9/70 , C07C53/136 , C07C59/11 , C07C59/13 , C07C69/28 , C07C69/675 , C07C69/68 , C07C69/708 , C07C69/712 , C07C69/74 , C07C69/75 , C07C69/96 , C07D305/08 , C07D307/24 , C07D307/30 , C07D309/08
CPC分类号: C07C69/734 , A61K9/7023 , C07C53/136 , C07C59/11 , C07C59/13 , C07C69/28 , C07C69/675 , C07C69/68 , C07C69/708 , C07C69/712 , C07C69/74 , C07C69/75 , C07C69/96 , C07D305/08 , C07D307/24 , C07D307/30 , C07D309/08 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07C2603/14
摘要: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
-
公开(公告)号:US20220055980A1
公开(公告)日:2022-02-24
申请号:US17207975
申请日:2021-03-22
申请人: CORSAIR PHARMA, INC.
IPC分类号: C07C69/734 , C07C69/74 , C07C53/136 , C07C59/11 , C07C59/13 , A61K9/70 , C07D309/08 , C07C69/708 , C07C69/712 , C07D305/08 , C07C69/675 , C07C69/68 , C07C69/75 , C07C69/96 , C07D307/24 , C07C69/28 , C07D307/30
摘要: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
-
公开(公告)号:US20210355072A1
公开(公告)日:2021-11-18
申请号:US17245235
申请日:2021-04-30
申请人: CORSAIR PHARMA, INC.
IPC分类号: C07C69/734 , C07C69/74 , C07C53/136 , C07C59/11 , C07C59/13 , A61K9/70 , C07D309/08 , C07C69/708 , C07C69/712 , C07D305/08 , C07C69/675 , C07C69/68 , C07C69/75 , C07C69/96 , C07D307/24 , C07C69/28 , C07D307/30
摘要: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
-
公开(公告)号:US20200347006A1
公开(公告)日:2020-11-05
申请号:US16880146
申请日:2020-05-21
申请人: CORSAIR PHARMA, INC.
IPC分类号: C07C69/734 , C07C69/74 , C07C53/136 , C07C59/11 , C07C59/13 , A61K9/70 , C07D309/08 , C07C69/708 , C07C69/712 , C07D305/08 , C07C69/675 , C07C69/68 , C07C69/75 , C07C69/96 , C07D307/24 , C07C69/28 , C07D307/30
摘要: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
-
公开(公告)号:US10780140B2
公开(公告)日:2020-09-22
申请号:US15832053
申请日:2017-12-05
申请人: John P. Crow, Jr.
发明人: John P. Crow, Jr.
IPC分类号: A61K36/61 , C07D307/32 , C07D307/30
摘要: The present invention relates to methods and strategies for extracting nitrosylated and/or nitrated derivatives and analogs from Myrciaria dubia fruit and for synthesizing the same. The ascorbic acid derivatives and analogs have the chemical structure of: where R1 is ═O, —ONO, —ONO2, or —NH2; R2 is —OH, —ONO, —ONO2, or —NH2; R3 is —OH, —ONO, —ONO2. The extraction method comprises freeze-drying the Myrciaria dubia fruit, mixing the freeze-dried powder with a solvent and separating and drying the supernatant. The synthetic method comprises derivatizing an ascorbic acid via nitrosylation and/or nitration in a buffered ascorbic acid solution, reducing zero or more nitro groups to an amine group, and purifying the ascorbic acid analog.
-
公开(公告)号:US10703706B2
公开(公告)日:2020-07-07
申请号:US16270965
申请日:2019-02-08
申请人: CORSAIR PHARMA, INC.
IPC分类号: C07C69/734 , C07C69/74 , C07C53/136 , C07C59/11 , C07C59/13 , A61K9/70 , C07D309/08 , C07C69/708 , C07C69/712 , C07D305/08 , C07C69/675 , C07C69/68 , C07C69/75 , C07C69/96 , C07D307/24 , C07C69/28 , C07D307/30
摘要: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
-
公开(公告)号:US10654839B2
公开(公告)日:2020-05-19
申请号:US15546167
申请日:2016-01-26
发明人: Jean-Simon Diallo , Christopher Noyce Boddy , Mark Dornan , Ramya Krishnan , Rozanne Arulanandam , Fabrice Le Boeuf , Jeffrey Smith , Andrew Macklin
IPC分类号: C07D207/36 , C07D413/06 , C07D237/14 , C07D207/38 , C07D307/60 , C07D307/66 , C07D401/06 , C07D403/06 , C07D405/04 , C07D405/12 , C07D409/06 , C07D307/30 , C07D307/58 , C07D405/06 , A61K45/06 , C12N7/00 , C07D207/456 , C07D317/64 , C07D417/06 , C07D471/04 , A61P35/02 , C07D209/48 , C07D231/08 , A61K31/341
摘要: Provided are compounds of Formula (II) that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the antigen expression from a virus, gene or trans-gene expression from a virus, or virus protein expression in cells. Other uses, compositions and methods of using same are also provided. Compounds of Formula (II):
-
公开(公告)号:US10450282B2
公开(公告)日:2019-10-22
申请号:US15750388
申请日:2016-08-05
IPC分类号: C07D498/04 , C07D209/86 , C07D209/88 , C07D275/06 , C07D291/08 , C07D265/38 , C07D401/04 , C07D405/04 , C07D413/04 , C07D417/04 , C07D307/30 , C07D285/01 , C07D301/14 , C07D309/28 , C07D419/04
摘要: A process for the stereoselective synthesis of chiral 3-heterocyclyl-1,2-dihydroxy cyclohexanes is disclosed. The process involves reacting a tricyclic nitrogenous heterocycle with an allyl carbonate in the presence of a chiral palladium catalyst followed by oxidation of the olefinic bond to provide 3-heterocyclyl-1,2-dihydroxy cyclohexanes, cyclopentanes and corresponding alicyclic heterocycles. Also disclosed are methods for converting the heterocyclyl-1,2-dihydroxy cyclohexanes to 2-amino-6-(heteroaryl)cyclohexanols (and related cyclic compounds).
-
-
-
-
-
-
-
-
-